Comparing immersive and non-immersive virtual reality for improving arm function in stroke patients
Immersive Versus Non-immersive Virtual Reality in Enhancing Upper Limb Functions Among Individuals With Subacute Stage Hemiplegia - A Randomized Controlled Trial
NA · Gulf Medical University · NCT06615141
This study is testing if using immersive virtual reality with regular therapy can help stroke patients improve their arm function better than using non-immersive virtual reality with the same therapy.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 28 Years to 55 Years |
| Sex | All |
| Sponsor | Gulf Medical University (other) |
| Locations | 1 site (Ajman) |
| Trial ID | NCT06615141 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of immersive virtual reality combined with conventional therapy versus non-immersive virtual reality combined with conventional therapy in enhancing upper limb function among individuals with subacute hemiplegia following a stroke. Participants aged 28-55 years will be randomly assigned to one of two groups, with both groups receiving conventional therapy alongside their respective virtual reality interventions. The primary outcomes will be measured using the Fugl Meyer Assessment and the Graded Wolf Motor Function test, while the secondary outcome will assess quality of life through the Stroke Specific Quality of Life Scale. Follow-up assessments will occur six weeks post-intervention to compare baseline and follow-up scores.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 28-55 years who have been diagnosed with hemiplegia due to stroke and meet specific motor recovery criteria.
Not a fit: Patients with severe motion sickness, photosensitive epilepsy, or pre-existing neurological conditions affecting upper limb function may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a novel therapeutic approach to significantly improve upper limb function in stroke patients.
How similar studies have performed: Other studies have shown promising results using virtual reality for rehabilitation, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals aged 28-55 years. * Diagnosed with hemiplegia due to stroke. * ≤ Grade 2 on Modified Ashworth scale. * ≤ Stage 2 on Brunnstrom stages of motor recovery. * Score of ≥ 35/36 on Cognitive assessment scale for stroke patients (CASP) Exclusion Criteria: * Contraindications for VR therapy, such as severe motion sickness or photosensitive epilepsy, impaired spatial awareness. * Pre-existing neurological conditions such as spinal cord injury, Multiple sclerosis and so affecting upper limb function.
Where this trial is running
Ajman
- Thumbay Physical Therapy and Rehabilitation Hospital — Ajman, United Arab Emirates (RECRUITING)
Study contacts
- Principal investigator: Athira George, Master of Physical Therapy — Gulf Medical University
- Study coordinator: Athira George, MPT
- Email: 2022mpt09@mygmu.ac.ae
- Phone: +971503723635
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hemiplegia and/or Hemiparesis Following Stroke, virtual reality, hemiplegic stroke, Oculus Quest 3, Motor function, Upper limb